Charlotte D. Jacobs M.D.
Publications
- A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC). Cancer Chemother Pharmacol. 2012; (3): 815-24
- The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2012; (2): 563-71
- Antiangiogenesis agents in the treatment of soft tissue sarcomas. Cancer. 2010; (5): 1177-83
- Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. Leuk Lymphoma. 2009; (11): 1882-4
- Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor. Case Rep Oncol. 2009; (3): 242-250
- The value of surgery for retroperitoneal sarcoma. Sarcoma. 2009: 605840
- Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. J Cancer Res Clin Oncol. 2008; (10): 1151-3
- Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report. J Neurosurg Spine. 2007; (5): 441-6
- A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance. Ann Oncol. 2005; (12): 1968-73
- Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003; (8): 521-5
- Impact of a program to diminish gender insensitivity and sexual harassment at a medical school. Acad Med. 2000; (5): 464-9
- Lymphomas of the head and neck. Semin Oncol. 1999; (3): 338-45
- Outcome measurement in postgraduate year one of graduates from a medical school with a pass/fail grading system. Acad Med. 1999; (5): 547-9
- Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Cancer J Sci Am. 1997 Sep-Oct; (5): 303-11
- The relationship of clinical knowledge to months of clinical training among medical students. Acad Med. 1997; (4): 305-7
- A climate survey for medical students. A means to assess change. Eval Health Prof. 1996; (1): 30-47
- A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncology (Williston Park). 1996; (3 Suppl): 16-20
- Status of the Medical Oncology Workforce Journal of Clinical Oncology. 1996; (9): 2612-2621.
- A multimodality approach to preparation for clinical medicine. Acad Med. 1995; (5): 441-2
- A sexual harassment workshop for medical students. Acad Med. 1995; (5): 434-5
- Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Semin Oncol. 1995; (6): 540-52
- Adjuvant and neoadjuvant treatment of head and neck cancers: the next chapter. Seminars in Oncology.. 1995; (6): 540-52.
- Distant metastases from head and neck squamous cancer: the role of adjuvant chemotherapy. Cancer Treat Res. 1995: 243-62
- Head and neck cancer - combined modality therapy and chemotherapy. Brian MC and Carbone PP (eds), Current Therapy in Hematology-Oncology, Mosby, St. Louis,. 1995: 352-358.
- Head and neck cancers Macdonald JS, Haller DG, Mayer RJ (eds), Manual of Oncologic Therapeutics, Third Edition, JB Lippincott, Philadelphia. 1995: 162-169.
- The value of medical student research: the experience at Stanford University School of Medicine. Med Educ. 1995; (5): 342-6
- A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol. 1992; (2): 257-63
- Adjuvant and neoadjuvant treatment of head and neck cancers. Semin Oncol. 1991; (6): 504-14
- Chemotherapy for recurrent and metastatic head and neck cancer. Hematol Oncol Clin North Am. 1991; (4): 667-86
- The use of probenecid as a chemoprotector against cisplatin nephrotoxicity. Cancer. 1991; (6): 1518-24
- Head and neck squamous cancers. Curr Probl Cancer. 1990 Jan-Feb; (1): 1-72
- A phase II trial of carbetimer for the treatment of colorectal cancer. A trial of the Northern California Oncology Group. Am J Clin Oncol. 1990; (4): 324-6
- Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program. J Clin Oncol. 1990; (5): 838-47
- Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol. 1990; (9): 1585-90
- The internist in the management of head and neck cancer. Ann Intern Med. 1990; (10): 771-8
- Adjuvant chemotherapy for head and neck cancer. J Clin Oncol. 1989; (7): 823-6
Help
Trial Administration